Drie potentiele nieuwe behandelingen tegen malaria ontwikkeld door GSK (waarvan twee samen met MMV) betreden inmiddels de klinische testfase.
Three potential new treatments for malaria being developed by GSK (two in partnership with MMV) are progressing to clinical trials.